Ergomed plc Notice of Results (8501N)
14 August 2017 - 4:00PM
UK Regulatory
TIDMERGO
RNS Number : 8501N
Ergomed plc
14 August 2017
PRESS RELEASE
FOR IMMEDIATE RELEASE
Notice of interim results
London, UK - 14 August 2017: Ergomed plc (LSE: ERGO) ('Ergomed'
or the 'Company'), a specialised pharmaceutical services and drug
development company, will announce its Interim Results for the six
months ended 30 June 2017 on Monday 18 September 2017.
Dr Dan Weng, Chief Executive Officer, and Stephen Stamp, Chief
Financial Officer, will host a presentation and conference call for
analysts at 9:00am BST on the day of the results at the offices of
Numis Securities, The London Stock Exchange Building, 10
Paternoster Square, London, EC4M 7LT.
ENDS
Enquiries:
Ergomed plc Tel: +44 (0)
1483 503205
Dan Weng (Chief Executive Officer)
Stephen Stamp (Chief Financial
Officer)
Numis Securities Limited Tel: +44 (0)
20 7260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black (Joint Broker)
N+1 Singer Tel: +44 (0)
20 7496 3000
Alex Price (Joint Broker)
Consilium Strategic Communications Tel: +44 (0)
- for UK enquiries 20 3709 5700
Chris Gardner / Mary-Jane ergomed@consilium-comms.com
Elliott
Ivar Milligan / Philippa Gardner
MC Services - for Continental Tel: +49 211
European enquiries 5292 5222
Anne Hennecke
About Ergomed
Ergomed provides specialist services to the pharmaceutical
industry and develops drugs both wholly-owned and through
partnerships. Ergomed's fast-growing, profitable service offering
spans all phases of clinical development and post-approval
pharmacovigilance and medical information. Drawing on more than 20
years of expertise in drug development, Ergomed is also building a
growing portfolio of drug development partnerships and programmes,
including wholly-owned proprietary products for the treatment of
surgical bleeding. For further information, visit:
http://ergomedplc.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORGGUCCRUPMPUW
(END) Dow Jones Newswires
August 14, 2017 02:00 ET (06:00 GMT)
Ergomed (LSE:ERGO)
Historical Stock Chart
From Apr 2024 to May 2024
Ergomed (LSE:ERGO)
Historical Stock Chart
From May 2023 to May 2024